The first BioTech Bootcamp program – an international collaboration between SmiLe, BioM and Merck – generated a lot of interest. The selected dozen participants, half of them women, work on developing and commercializing their business ideas with international Life Science experts.
BioTech Bootcamp is a new, eight-week digital mentoring program, where the participants have the opportunity to develop their business ideas in biotech, pharma or diagnostics while working on their entrepreneurial skills and connecting with mentors, experts and industry professionals. In addition, a personal mentor has been designated to each of the participants to coach them throughout the entire eight-week program. It was kicked off on September 7th.
The participants selected for this first training program come from Germany, the Nordics, Spain and Greece. All of them have PhDs and what’s more; half of the participants are women. Between them they represent a number of different fields and backgrounds, and their business ideas cover a wide variety of disciplines, from drug development to diagnostics in many different areas; from treating hairloss, asthma and arthritis to drug-delivery, biomarkers and immunotherapies.
“I am very proud that the first SmiLe BioTech Bootcamp has attracted so many top-level participants and I’m especially pleased to see that more than half of them are women. The wide variety, high quality and potential of the business ideas in this program is impressive and I am looking forward to seeing the development of some exciting new BioTech breakthroughs," says Ebba Fåhraeus, CEO of SmiLe.
During the first six weeks the participants will work on validating and developing their business ideas through expert lectures, individual coaching and expert mentoring from international Life Science players like Merck, BioM, SmiLe, Boehringer Ingelheim, Bayer, Abbvie etc. The program ends with the BioEntrepreneurship Summit week run by BioM, on October 18-22, where the participants have the opportunity to meet other European entrepreneurs, representatives of the pharmaceutical industry and investors. After completing the program, two winners will also be awarded with a trip to Mercks’ M Lab™ Collaboration Center in Molsheim, France.
For more information: Ebba Fåhraeus, CEO of SmiLe, +46 73 400 04 33, email@example.com
SmiLe Incubator is a life science business incubator based in Medicon Village in Lund, Sweden. SmiLe helps entrepreneurs commercialize their ideas. There are currently 25 companies in SmiLe which, together with alumni companies, have attracted more than EUR 460 million in venture capital to date since 2014. SmiLe offers excellent business coaching, a broad international network of contacts and a dynamic community, as well as well-equipped laboratories which is unique of its kind in Sweden. SmiLe is a non-profit organization and receives basic funding from Region Skåne, Lund Municipality, Lund University and Medicon Village. SmiLe´s sponsors are Agilent, Sparbanken Skåne, Awa, Høiberg, Prevas, Setterwalls, Zacco, Aqilion. SmiLe’s listed alumni companies have a market capitalization of EUR 1,3 billion (Q1 2021). www.smileincubator.life